Letter to healthcare professionals on 04/02/2020: Prevention of Severe Respiratory Disease associated with a Novel Infectious Agent (3rd letter)
Letter to healthcare professionals on
04/02/2020: Prevention of Severe Respiratory Disease associated with a
Novel Infectious Agent (3rd letter)
Dear Sir / Madam,
Further
to the previous email dated 23 Jan 2020, we would like to provide you
updates on the development of novel coronavirus (nCoV) infection and
step-up recommendations on the infection control measures and advice.
As
of 2 Feb 2020, there were 15 confirmed cases of nCoV infection in Hong
Kong. The place of infection of two cases were under investigation but
the possibility of locally acquired infections exist. There is clear
evidence of human-to-human transmission of nCoV. Besides, it was
reported that cases might be infectious even before the onset of
symptoms. In this connection, we would like to alert healthcare workers
to remain vigilant in adopting stringent infection control measures to
reduce the risk of transmission from silent or suspected patients in
healthcare settings. Healthcare workers are advised to follow the
relevant recommendations and interim guidelines as listed in the
attached letter.
I should be most grateful if you could pass the letter to members of your society / association.
Yours sincerely,
(Dr Kellie SO)
for Director of Health
沒有留言:
發佈留言